447 filings
Page 3 of 23
6-K
yo6fsb6
7 Jul 23
Current report (foreign)
4:30pm
6-K
yxgn8 b12z9zfrq47l
6 Jul 23
Current report (foreign)
8:30am
6-K
cn4zctgi xpbty0y9o
5 Jul 23
Akari Therapeutics Appoints Industry Veteran Wa’el Hashad to Board of Directors
8:30am
6-K
lrsx3i
30 Jun 23
Current report (foreign)
4:30pm
EFFECT
hlx47rs
7 Jun 23
Notice of effectiveness
12:15am
EFFECT
h7yoh 93viw82vt4
7 Jun 23
Notice of effectiveness
12:15am
6-K
g2ywnl5kh7vzwdqjqk2t
6 Jun 23
This Document Is Important and Requires Your Immediate Attention
8:59am
POS AM
udnyq8ib9y92
31 May 23
Prospectus update (post-effective amendment)
5:07pm
POS AM
ayt0um2u ry7jzj
31 May 23
Prospectus update (post-effective amendment)
5:03pm
S-8
rk4oqi a3tw1n
31 May 23
Registration of securities for employees
4:39pm
6-K
sy2u7701o 0lpb1yinn
22 May 23
Current report (foreign)
8:30am
6-K
f6e3s zxs
5 May 23
Current report (foreign)
8:00am
6-K
rhb 7o2eyf8le2t6
3 May 23
Current report (foreign)
5:00pm
6-K
fmqwulzl tg
1 May 23
Akari Therapeutics Reports Full-Year 2022
8:05am
6-K
jzb6h9ee3de027
25 Apr 23
Akari Therapeutics Granted 180-Day Extension by Nasdaq to Meet Minimum Bid Price Requirement
4:20pm
6-K
dmtbqtmqk zvlhnd
31 Mar 23
Akari Therapeutics, Plc Announces $4 Million Registered Direct Offering
10:31am
424B5
e80p4swf2lk 9bl5
31 Mar 23
Prospectus supplement for primary offering
10:29am
6-K
qwm05s uagdjtnp
29 Mar 23
Current report (foreign)
9:00am
6-K
pawrj8ivsawke32ldus
28 Mar 23
Current report (foreign)
9:03am